JPMorgan Chase & Co’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.95B | Sell |
|
|||||
|
2025
Q2 | $2.09B | Buy |
|
|||||
|
2025
Q1 | $1.59B | Buy |
|
|||||
|
2024
Q4 | $1.1B | Buy |
|
|||||
|
2024
Q3 | $559M | Sell |
|
|||||
|
2024
Q2 | $802M | Sell |
|
|||||
|
2024
Q1 | $917M | Buy |
|
|||||
|
2023
Q4 | $597M | Buy |
|
|||||
|
2023
Q3 | $242M | Buy |
|
|||||
|
2023
Q2 | $300M | Buy |
|
|||||
|
2023
Q1 | $200M | Buy |
|
|||||
|
2022
Q4 | $136M | Sell |
|
|||||
|
2022
Q3 | $167M | Buy |
|
|||||
|
2022
Q2 | $187M | Buy |
|
|||||
|
2022
Q1 | $153M | Buy |
|
|||||
|
2021
Q4 | $143M | Sell |
|
|||||
|
2021
Q3 | $126M | Sell |
|
|||||
|
2021
Q2 | $119M | Sell |
|
|||||
|
2021
Q1 | $152M | Buy |
|
|||||
|
2020
Q4 | $160M | Buy |
|
|||||
|
2020
Q3 | $135M | Buy |
|
|||||
|
2020
Q2 | $98.1M | Sell |
|
|||||
|
2020
Q1 | $153M | Buy |
|
|||||
|
2019
Q4 | $82.6M | Buy |
|
|||||
|
2019
Q3 | $72.2M | Sell |
|
|||||
|
2019
Q2 | $75.9M | Sell |
|
|||||
|
2019
Q1 | $143M | Buy |
|
|||||
|
2018
Q4 | $114M | Buy |
|
|||||
|
2018
Q3 | $128M | Sell |
|
|||||
|
2018
Q2 | $115M | Buy |
|
|||||
|
2018
Q1 | $79.8M | Sell |
|
|||||
|
2017
Q4 | $71.8M | Buy |
|
|||||
|
2017
Q3 | $61.4M | Buy |
|
|||||
|
2017
Q2 | $62.8M | Sell |
|
|||||
|
2017
Q1 | $50.7M | Sell |
|
|||||
|
2016
Q4 | $62.9M | Sell |
|
|||||
|
2016
Q3 | $109M | Sell |
|
|||||
|
2016
Q2 | $108M | Buy |
|
|||||
|
2016
Q1 | $88.8M | Buy |
|
|||||
|
2015
Q4 | $68.7M | Buy |
|
|||||
|
2015
Q3 | $59.6M | Sell |
|
|||||
|
2015
Q2 | $60.2M | Buy |
|
|||||
|
2015
Q1 | $50M | Sell |
|
|||||
|
2014
Q4 | $57.8M | Sell |
|
|||||
|
2014
Q3 | $67.2M | Buy |
|
|||||
|
2014
Q2 | $10.7M | Sell |
|
|||||
|
2014
Q1 | $31M | Buy |
|
|||||
|
2013
Q4 | $17M | Sell |
|
|||||
|
2013
Q3 | $23.4M | Sell |
|
|||||
|
2013
Q2 | $22.8M | Buy |
|